TGF-β signalling regulator PMEPA1 halts metastases to bone

被引：2
|
作者：
Louise Stone
机构：
来源：
Nature Reviews Urology | 2015年 / 12卷 / 7期
关键词：
D O I：
10.1038/nrurol.2015.136
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：362 / 362
相关论文
共 50 条
  • [1] The TGF-β Signaling Regulator PMEPA1 Suppresses Prostate Cancer Metastases to Bone
    Fournier, Pierrick G. J.
    Juarez, Patricia
    Jiang, Guanglong
    Clines, Gregory A.
    Niewolna, Maria
    Kim, Hun Soo
    Walton, Holly W.
    Peng, Xiang Hong
    Liu, Yunlong
    Mohammad, Khalid S.
    Wells, Clark D.
    Chirgwin, John M.
    Guise, Theresa A.
    CANCER CELL, 2015, 27 (06) : 809 - 821
  • [2] TGF-β Activates Prostate Cancer Bone Metastases, Pro-Osteolytic Gene Expression and the New TGF-β Signaling Regulator PMEPA1
    Fournier, P. G. J.
    Clines, G. A.
    Chirgwin, J. M.
    Guise, T. A.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2008, 23 : S186 - S186
  • [3] TGF-β promotes prostate cancer bone metastases and increases expression of pro-osteolytic genes and of the TGF-β signaling regulator PMEPA1
    Fournier, P. G.
    Clines, G. A.
    Chirgwin, J. M.
    Guise, T. A.
    CLINICAL & EXPERIMENTAL METASTASIS, 2008, 25 : 26 - 27
  • [4] Transforming growth factor-β (TGF-β) promotes prostate cancer bone metastases:: Increased expression of pro-osteolytic genes and of PMEPA1, a new TGF-β signalling regulator
    Fournier, Pierrick
    Clines, Gregory
    Chirgwin, John
    Guise, Theresa
    CANCER TREATMENT REVIEWS, 2008, 34 : S67 - S67
  • [5] TGF-β-regulated genes, IL-11, PTHrP and PMEPA1, are increased in bone metastases.
    Fournier, P. G.
    Mohammad, K. S.
    Chirgwin, J. M.
    Guise, T. A.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2006, 21 : S219 - S219
  • [6] PMEPA1 is an oncogene linked to TGF-ß signaling in hepatocellular carcinoma
    Pique-Gili, Marta
    Andreu-Oller, Carmen
    Pinyol, Roser
    Barcena-Varela, Marina
    Esteban-Fabro, Roger
    Peix, Judit
    Abril-Fornaguera, Jordi
    Lindblad, Katherine E.
    Torres-Martin, Miguel
    Sia, Daniela
    Lujambio, Amaia
    Llovet, Josep M.
    CANCER RESEARCH, 2022, 82 (12)
  • [7] TGF-β oncogenic pathway in HCC: PMEPA1 as a biomarker of treatment response
    Quetglas, I. M.
    Sia, D.
    Jiao, Y.
    Maeda, M.
    Castro, M.
    Esteller, M.
    Llovet, J. M.
    JOURNAL OF HEPATOLOGY, 2017, 66 (01) : S466 - S466
  • [8] PMEPA1 induces EMT via a non-canonical TGF-β signalling n colorectal cancer
    Zhang, Lei
    Wang, Xue
    Lai, Chong
    Zhang, Honghe
    Lai, Maode
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2019, 23 (05) : 3603 - 3615
  • [9] PMEPA1 has an oncogenic role in the context of TGF-β signaling in hepatocellular carcinoma
    Pique-Gili, Marta
    Andreu-Oller, Carmen
    Pinyol, Roser
    Esteban, Roger
    Barcena-Varela, Marina
    Peix, Judit
    Abril-Fornaguera, Jordi
    Lindblad, Katherine E.
    Torres-Martin, Miguel
    Huguet-Pradell, Julia
    Sia, Daniela
    Lujambio, Amaia
    Llovet, Josep M.
    CLINICAL CANCER RESEARCH, 2022, 28 (17)
  • [10] Oncogenic role of PMEPA1 and its association with immune exhaustion and TGF-β activation in HCC
    Pique-Gili, Marta
    Andreu-Oller, Carmen
    Mesropian, Agavni
    Esteban-Fabro, Roger
    Barcena-Varela, Marina
    de Galarreta, Marina Ruiz
    Montironi, Carla
    Martinez-Quetglas, Iris
    Cappuyns, Sarah
    Peix, Judit
    Keraite, Ieva
    Gris-Oliver, Albert
    Fernandez-Martinez, Elisa
    Mauro, Ezequiel
    Torres-Martin, Miguel
    Abril-Fornaguera, Jordi
    Lindblad, Katherine E.
    Lambrechts, Diether
    Dekervel, Jeroen
    Thung, Swan N.
    Sia, Daniela
    Lujambio, Amaia
    Pinyol, Roser
    Llovet, Josep M.
    JHEP REPORTS, 2024, 6 (11)
12345